Concepedia

SubbaReddy Gunneri

SG

Statistics

Publications

3

Citations

74

H-Index

3

Active since

2022

Affiliations

Translational Health Science and Technology Institute(Current)

Biological E (India)

St. Theresa’s Multi-Speciality Hospital

ESIC Hospital

All India Institute of Medical Sciences

SubbaReddy Gunneri is an author at Translational Health Science and Technology Institute specializing in immunotherapy, vaccine development, and vaccine safety.

Top concepts

Publications per year

2022–2023

3

Publications

3

Safety, tolerability and immunogenicity of Biological E’s CORBEVAX™ vaccine in children and adolescents: A prospective, randomised, double-blind, placebo controlled, phase-2/3 study

Subhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri et al. · Vaccine · 2022 · 33 citations

, , +10

Immunogenicity and safety of Biological E’s CORBEVAX™ vaccine compared to COVISHIELD™ (ChAdOx1 nCoV-19) vaccine studied in a phase-3, single blind, multicentre, randomized clinical trial

Subhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri et al. · Human Vaccines & Immunotherapeutics · 2023 · 31 citations · Full text

Selection of optimum formulation of RBD-based protein sub-unit covid19 vaccine (Corbevax) based on safety and immunogenicity in an open-label, randomized Phase-1 and 2 clinical studies

Subhash Thuluva, Vikram Paradkar, Kishore Turaga et al. · 2022 · 10 citations · Full text

1–3 of 3